A Phase I Trial Defining the Maximum Tolerated Systemic Exposure of Topotecan in Combination with Carboplatin and Etoposide in Extensive Stage Small Cell Lung Cancer

Author: Gillenwater Heidi   McCune Jeannine   Lindley Celeste   Faucette Stephanie   Shord Stacy   Donahue Angela   Socinski Mark   Stewart Clinton   Zamboni William   Kirstein Mark   Moore Dominic  

Publisher: Informa Healthcare

ISSN: 0735-7907

Source: Cancer Investigation, Vol.23, Iss.6, 2005-09, pp. : 511-519

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content